Dr Copson is Associate Professor and honorary consultant in Medical Oncology at the University of Southampton, where she specialises in treating breast cancer. Following a PhD studying the molecular genetics of the BRCA1 gene, Dr Copson has a particular interest in the genomic and modifiable host factors which influence outcomes of early breast cancer. She is a lead researcher on the POSH study, a large national cohort study of young breast cancer patients and is involved with a number of research studies investigating various aspects of breast cancer genomics and body composition/ nutrition in cancer. She is also principle investigator for many clinical trials in early and advanced breast cancer.
Dr Copson is Cancer lead of the Wessex Genomic Medical Centre and Chair of the Wessex Molecular Tumour Board. She has a strong interest in oncology training and is chair of the National Oncogenetics Training Working Party, a member of the RCP Specialist Examination Board and a member of the RCR Clinical Oncology Academic Committee. Dr Copson was a NIHR Breast Cancer Clinical Studies Group (CSG) member from 2013 to 2019 and led the development of a new national Breast Cancer Trainees Research Collaborative Group which she continues to chair.